Clinical Trial Update: Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating sirolimus in combination with durvalumab for stage I–IIIA non-small cell lung cancer. The study is terminated with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• Rapamune (sirolimus)

Snippet

Sponsor: Emory University | Conditions: Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 | Phase 1 | Status: TERMINATED | Results posted: 2024-08-22